Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
UPDATE: Mountain Crest Acquisition Corp (MCAC) Prices 5M Unit IPO at $10/Unit
-
Mountain Crest Acquisition Corp Announces Pricing of $50 Million Initial Public Offering
-
Form 10-Q Chardan Healthcare Acqui For: Mar 31
-
Prevail Therapeutics to Participate in Fireside Chat at Chardan 4th Annual Genetic Medicines Manufacturing Summit
-
Prevail Therapeutics to Participate in Fireside Chat at Chardan 4th Annual Genetic Medicines Manufacturing Summit
-
UPDATE: Krystal Biotech (KRYS) Prices 2.275M Share Common Offering at $55/Sh
-
Krystal Biotech Announces Pricing of $125 Million Public Offering of Common Stock
-
Wealthbridge Acquisition Limited and Scienjoy Inc. Announce Closing of Business Combination
-
Form SC 13G Chardan Healthcare Acqui Filed by: Oliveira Steven Michael
-
UPDATE: Chardan Capital Markets Starts Madrigal Pharmaceuticals (MDGL) at Buy
-
UPDATE: Chardan Capital Markets Starts Viking Therapeutic (VKTX) at Buy
-
Form 8-K Chardan Healthcare Acqui For: Apr 28
-
Emergent BioSolutions (EBS) PT Raised to $86 at Chardan Capital Markets
-
NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Form 8-K Chardan Healthcare Acqui For: Apr 23
-
Chardan Healthcare Acquisition 2 Corp. Announces Closing of $85 Million Initial Public Offering
-
Form 424B4 Chardan Healthcare Acqui
-
NeuBase Therapeutics (NBSE) Prices 5.25M Share Common Offering at $6/Sh
-
NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock
-
Moderna (MRNA) PT Raised to $52 at Chardan Capital After COVID-19 Vaccine Phase 2 IND Filed
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Session R.A. II
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Manke Isaac
-
Form EFFECT Chardan Healthcare Acqui
-
Chardan Healthcare Acquisition 2 Corp. (CHAQ) Prices 8.5M Unit IPO at $10/Unit
-
Chardan Healthcare Acquisition 2 Corp. Announces Pricing of $85 Million Initial Public Offering
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: GROSSMAN JONAS
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Giroux Richard
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Rice Michael Yehuda
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Rossen Matthew
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Barudin Guy
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Kaufman George
-
Form 3 Chardan Healthcare Acqui For: Apr 23 Filed by: Amusa Gbolahan
-
Form CERT Chardan Healthcare Acqui
-
Form 8-A12B/A Chardan Healthcare Acqui
-
Form 8-A12B Chardan Healthcare Acqui
-
Form S-1/A Chardan Healthcare Acqui
-
Immunovant Announces Closing of $139.4 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Form S-1/A Chardan Healthcare Acqui
-
Immunovant (IMVT) Announces Pricing of $121.2 Million Public Offering of Common Stock
-
Immunovant Announces Pricing of $121.2 Million Public Offering
-
UPDATE - EdtechX Holdings and Meten International Announce Successful Merger Closing and Capital Raise
-
UPDATE - EdtechX Holdings and Meten International Announce Successful Merger Closing and Capital Raise
-
Chardan Acts as M&A and Capital Markets Advisor in EdtechX Holdings' Completed Merger with Meten Education (China)
-
EdtechX Holdings (NASDAQ:EDTX) and Meten International Announce Successful Merger Closing and Capital Raise
-
EdtechX Holdings and Meten International Announce Successful Merger Closing and Capital Raise
-
EdtechX Holdings and Meten International Announce Successful Merger Closing and Capital Raise
-
ReCode Therapeutics Raises $80 Million in Oversubscribed Series A Financing
-
BiomX Reports Full Year 2019 Financial Results and Provides Business Update
-
LifeSci Acquisition Corp. Announces Partial Exercise and Closing of Over-Allotment Option in Public Offering
-
Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies

